ES2086518T3 - Compuesto farmaceutico con accion cicatrizante. - Google Patents

Compuesto farmaceutico con accion cicatrizante.

Info

Publication number
ES2086518T3
ES2086518T3 ES91830353T ES91830353T ES2086518T3 ES 2086518 T3 ES2086518 T3 ES 2086518T3 ES 91830353 T ES91830353 T ES 91830353T ES 91830353 T ES91830353 T ES 91830353T ES 2086518 T3 ES2086518 T3 ES 2086518T3
Authority
ES
Spain
Prior art keywords
pharmaceutical compound
compound
healing action
healing
pharmaceutical
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES91830353T
Other languages
English (en)
Inventor
Decimo Guarnieri
Piera Fileccia
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
IDI Farmaceutici SpA
Original Assignee
IDI Farmaceutici SpA
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by IDI Farmaceutici SpA filed Critical IDI Farmaceutici SpA
Application granted granted Critical
Publication of ES2086518T3 publication Critical patent/ES2086518T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K38/00—Medicinal preparations containing peptides
    • A61K38/16—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
    • A61K38/43—Enzymes; Proenzymes; Derivatives thereof
    • A61K38/44—Oxidoreductases (1)
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/30—Macromolecular organic or inorganic compounds, e.g. inorganic polyphosphates
    • A61K47/32—Macromolecular compounds obtained by reactions only involving carbon-to-carbon unsaturated bonds, e.g. carbomers, poly(meth)acrylates, or polyvinyl pyrrolidone
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12Y—ENZYMES
    • C12Y111/00—Oxidoreductases acting on a peroxide as acceptor (1.11)
    • C12Y111/01—Peroxidases (1.11.1)
    • C12Y111/01006—Catalase (1.11.1.6)

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Veterinary Medicine (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Public Health (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Engineering & Computer Science (AREA)
  • Immunology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Genetics & Genomics (AREA)
  • Biochemistry (AREA)
  • Gastroenterology & Hepatology (AREA)
  • Inorganic Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Dermatology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)

Abstract

SE EXPONE UN COMPUESTO FARMACEUTICO QUE MUESTRA UN EFECTO CICATRIZANTE QUE COMPRENDE LA ENZIMA CATALASA COMO AGENTE ACTIVO TERAPEUTICO Y UN VEHICULO FARMACEUTICAMENTE COMPATIBLE EN FORMA DE GEL. EL COMPUESTO CONTIENE TAMBIEN GENTAMICINA ANTIBIOTICA. EL COMPUESTO ENCUENTRA UTILIZACION EN LA CICATRIZACION DE ULCERAS, HERIDAS Y QUEMADURAS.
ES91830353T 1990-08-30 1991-08-21 Compuesto farmaceutico con accion cicatrizante. Expired - Lifetime ES2086518T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
IT48244A IT1241994B (it) 1990-08-30 1990-08-30 Composizione farmaceutica ad effetto cicatrizzante.

Publications (1)

Publication Number Publication Date
ES2086518T3 true ES2086518T3 (es) 1996-07-01

Family

ID=11265451

Family Applications (1)

Application Number Title Priority Date Filing Date
ES91830353T Expired - Lifetime ES2086518T3 (es) 1990-08-30 1991-08-21 Compuesto farmaceutico con accion cicatrizante.

Country Status (6)

Country Link
EP (1) EP0477143B1 (es)
AT (1) ATE136787T1 (es)
DE (1) DE69118796T2 (es)
DK (1) DK0477143T3 (es)
ES (1) ES2086518T3 (es)
IT (1) IT1241994B (es)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE69941459D1 (de) * 1998-08-28 2009-11-05 Univ Bath Bath Verfahren zur herstellung von essbaren zusammenstellungen mit antibakteriellen wirkstoffen
FR2809310B1 (fr) 2000-05-26 2004-02-13 Centre Nat Rech Scient Utilisation de derives de biguanide pour fabriquer un medicament ayant un effet cicatrisant

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
FR1118M (fr) * 1961-03-17 1962-02-12 Rech S Ind S O R I Soc D La catalase, son introduction en thérapeutique humaine comme accélérateur de la fibrogenese.
DE1252610B (de) * 1964-01-08 1967-10-26 SINCOREP SA, Fnbourg (Schweiz) Verfahren zum Stabilisieren von Katalase

Also Published As

Publication number Publication date
IT9048244A1 (it) 1992-03-01
EP0477143B1 (en) 1996-04-17
EP0477143A3 (en) 1993-02-24
IT9048244A0 (it) 1990-08-30
DK0477143T3 (da) 1996-07-08
EP0477143A2 (en) 1992-03-25
DE69118796D1 (de) 1996-05-23
DE69118796T2 (de) 1996-10-24
ATE136787T1 (de) 1996-05-15
IT1241994B (it) 1994-02-02

Similar Documents

Publication Publication Date Title
DE69530124D1 (de) Liposomale antibakterielle zusammensetzung mit geringer festigkeit
DE69826644D1 (de) Topische pharmazeutische zusammensetzung, enthaltend einen cholinergischen wirkstoff oder einen kalziumkanalblocker
EP0391905A4 (en) Hemorrhoidal, other compositions and methods of treatment
ES2155931T3 (es) Forma de administracion de un agente activo de liberacion prolongada en banda.
ES2039253T3 (es) Vendaje medico.
AU681452B2 (en) Pernasal composition and pernasal preparation containing thesame
ES2166783T3 (es) Factor viii activado utilizado como agente terapeutico y metodo para el tratamiento de la deficiencia de factor viii.
FI922325A (fi) Oral sammansaettning foer botning av inflammatoriska tarmkanalsjukdomar.
AR016798A1 (es) Uso de una cepa de lactobacillus para la elaboracion de un medicamento
ES2135703T3 (es) Composicion y procedimiento destinados para prevenir y tratar las inflamaciones con la ayuda de inmunoglobulina.
IE40860L (en) N- heterocyclylalkylbenzamides
PT904067E (pt) Dextrometorfan como agente antitussico administrado transdermicamente
ES2080037T1 (es) Medicamento de uso topico con actividad cicatrizante.
ES2086518T3 (es) Compuesto farmaceutico con accion cicatrizante.
CO4960657A1 (es) Composicion farmaceutica
ES2090167T3 (es) Uso topico de glicosaminoglicanos en la prevencion y el tratamiento de enfermedades que afectan al tracto vaginal cervical.
MY106036A (en) Preventing agent for human immunodeficiency virus infection comprising menfegol.
AR010432A1 (es) Composiciones farmaceuticas que contienen acido ricinoleico y su uso para la terapia antiinflamatoria y analgesica
ES2061821T3 (es) Utilizacion terapeutica del derivado ester isopropilo de monosialgangliosido en patologias nerviosas con componente inflamatoria.
CO5011042A1 (es) Uso de una oxazolidinona para la fabricacion de un medicamento para administracion topica
NO991047L (no) Transdermal terapeutisk tilnµrming involverende en kombinasjon av aktive substanser inneholdende °striol
OA09771A (en) Asphodelus composition for increasing white blood cell count.
GEP20002177B (en) Ointment “Levaskani” for Treatment of Wounds and Burns
UA30143A (uk) Лікувальний препарат для профілактики та лікування інфекційних та запальних захворювань
ES2036447A1 (es) Aposito estratificado de multiples capas.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 477143

Country of ref document: ES